ElevateBio: 2023 CNBC Disruptor 50
With biotech partners including Moderna, ElevateBio brings deep lab expertise to the emerging race for life-saving gene and cell therapies.
Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With biotech partners including Moderna, ElevateBio brings deep lab expertise to the emerging race for life-saving gene and cell therapies.
SNIPR Biome ApS ("SNIPR"), the company pioneering CRISPR-based microbial gene therapy, announces today that Nature Biotechnology has published research findings from its preclinical work on SNIPR001, the first CRISPR-armed phage therapeutic developed to specifically target and remove E. coli, including antibiotic-resistant strains, in the human gastrointestinal tract.
Kevin Davies, PhD, executive editor, The CRISPR Journal and GEN Biotechnology, discusses how CRISPR technology has seen success and potential areas for future application.
The education project will ultimately address educational disparities and develop agricultural and science literacy in Hawaiʻi.
Scientists said they have designed nanoparticle sensors that could diagnose early-stage cancer through a simple urine tests on a strip of paper.